These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22201736)

  • 41. Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer.
    Ban HS; Han TS; Hur K; Cho HS
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deregulated chromatin remodeling in the pathobiology of brain tumors.
    Spyropoulou A; Piperi C; Adamopoulos C; Papavassiliou AG
    Neuromolecular Med; 2013 Mar; 15(1):1-24. PubMed ID: 23114751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trials with 'epigenetic' drugs: an update.
    Nebbioso A; Carafa V; Benedetti R; Altucci L
    Mol Oncol; 2012 Dec; 6(6):657-82. PubMed ID: 23103179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer's epigenetic drugs: where are they in the cancer medicines?
    Ghasemi S
    Pharmacogenomics J; 2020 Jun; 20(3):367-379. PubMed ID: 31819161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromatin, cancer and drug therapies.
    Cortez CC; Jones PA
    Mutat Res; 2008 Dec; 647(1-2):44-51. PubMed ID: 18691602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic effects of nano-sized materials.
    Stoccoro A; Karlsson HL; Coppedè F; Migliore L
    Toxicology; 2013 Nov; 313(1):3-14. PubMed ID: 23238276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements.
    Singh D; Khan MA; Siddique HR
    Epigenomics; 2023 Apr; 15(8):517-537. PubMed ID: 37313832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic inhibitors and their role in cancer therapy.
    Abdelaziz N; Therachiyil L; Sadida HQ; Ali AM; Khan OS; Singh M; Khan AQ; Akil ASA; Bhat AA; Uddin S
    Int Rev Cell Mol Biol; 2023; 380():211-251. PubMed ID: 37657859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plant-derived epigenetic modulators for cancer treatment and prevention.
    Schnekenburger M; Dicato M; Diederich M
    Biotechnol Adv; 2014 Nov; 32(6):1123-32. PubMed ID: 24699435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic transitions: towards therapeutic targets.
    Kalebic T
    Expert Opin Ther Targets; 2003 Dec; 7(6):693-9. PubMed ID: 14640906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
    Akram F; Tanveer R; Andleeb S; Shah FI; Ahmad T; Shehzadi S; Akhtar AM; Syed G
    Technol Cancer Res Treat; 2024; 23():15330338241250317. PubMed ID: 38780251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting histone modifications--epigenetics in cancer.
    Waldmann T; Schneider R
    Curr Opin Cell Biol; 2013 Apr; 25(2):184-9. PubMed ID: 23347561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic modifications as therapeutic targets.
    Kelly TK; De Carvalho DD; Jones PA
    Nat Biotechnol; 2010 Oct; 28(10):1069-78. PubMed ID: 20944599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deregulation of epigenetic mechanisms in cancer.
    Maleszewska M; Wojtas B; Kamińska B
    Postepy Biochem; 2018 Oct; 64(2):148-156. PubMed ID: 30656897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overview of Histone Modification.
    Zhang Y; Sun Z; Jia J; Du T; Zhang N; Tang Y; Fang Y; Fang D
    Adv Exp Med Biol; 2021; 1283():1-16. PubMed ID: 33155134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic changes in the myelodysplastic syndrome.
    Issa JP
    Hematol Oncol Clin North Am; 2010 Apr; 24(2):317-30. PubMed ID: 20359628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.